B-raf Peptide Reference: GTX85102-PEP B-raf peptide is used for blocking the activity of B-raf antibody (catalog number GTX8512). It usually blocks the antibody activity completely in Western blot by incubating the peptide with equal volume of antibody for 3 min at 37oC.
Recombinant Human FGF-2 (147) Reference: GFH28-10 Fibroblast Growth Factor 2 (FGF-2) is expressed by endothelial cells and is a mediator of angiogenesis. FGF-2 also has cardioprotective functions during heart injury. The application of FGF-2 is a critical component for embryonic stem cell culture systems and is necessary for maintaining cells in an undifferentiated state. Degredation of the full length FGF-2 N-terminus results in a truncated FGF-2 147 amino acids protein, when the protein is isolated from biological sources. The N-terminus extensions influence the localization of FGF-2 within the cell, but do not affect the biological activity of FGF-2. Therefore, there are no detectable differences in biological activity between the full length FGF-2 154 amino acids and the truncated FGF-2 147 amino acids recombinant proteins.
SIRT7 Peptide Reference: GTX85103-PEP SIRT7 peptide is used for blocking the activity of SIRT7 antibody (catalog number GTX8513). It usually blocks the antibody activity completely in Western blot by incubating the peptide with equal volume of antibody for 3 min at 37oC.
Recombinant Human FGF-2 (147) Reference: GFH28-50 Fibroblast Growth Factor 2 (FGF-2) is expressed by endothelial cells and is a mediator of angiogenesis. FGF-2 also has cardioprotective functions during heart injury. The application of FGF-2 is a critical component for embryonic stem cell culture systems and is necessary for maintaining cells in an undifferentiated state. Degredation of the full length FGF-2 N-terminus results in a truncated FGF-2 147 amino acids protein, when the protein is isolated from biological sources. The N-terminus extensions influence the localization of FGF-2 within the cell, but do not affect the biological activity of FGF-2. Therefore, there are no detectable differences in biological activity between the full length FGF-2 154 amino acids and the truncated FGF-2 147 amino acids recombinant proteins.
SIRT5 Peptide Reference: GTX85104-PEP SIRT5 peptide is used for blocking the activity of SIRT5 antibody (catalog number GTX8514). It usually blocks the antibody activity completely in Western blot by incubating the peptide with equal volume of antibody for 3 min at 37oC.
Recombinant Human FGF-2 (147) Reference: GFH28-100 Fibroblast Growth Factor 2 (FGF-2) is expressed by endothelial cells and is a mediator of angiogenesis. FGF-2 also has cardioprotective functions during heart injury. The application of FGF-2 is a critical component for embryonic stem cell culture systems and is necessary for maintaining cells in an undifferentiated state. Degredation of the full length FGF-2 N-terminus results in a truncated FGF-2 147 amino acids protein, when the protein is isolated from biological sources. The N-terminus extensions influence the localization of FGF-2 within the cell, but do not affect the biological activity of FGF-2. Therefore, there are no detectable differences in biological activity between the full length FGF-2 154 amino acids and the truncated FGF-2 147 amino acids recombinant proteins.
SIRT3 Peptide Reference: GTX85105-PEP SIRT3 peptide is used for blocking the activity of SIRT3 antibody (catalog number GTX8515). It usually blocks the antibody activity completely in Western blot by incubating the peptide with equal volume of antibody for 3 min at 37oC.
Recombinant Human FGF-2 (147) Reference: GFH28-1000 Fibroblast Growth Factor 2 (FGF-2) is expressed by endothelial cells and is a mediator of angiogenesis. FGF-2 also has cardioprotective functions during heart injury. The application of FGF-2 is a critical component for embryonic stem cell culture systems and is necessary for maintaining cells in an undifferentiated state. Degredation of the full length FGF-2 N-terminus results in a truncated FGF-2 147 amino acids protein, when the protein is isolated from biological sources. The N-terminus extensions influence the localization of FGF-2 within the cell, but do not affect the biological activity of FGF-2. Therefore, there are no detectable differences in biological activity between the full length FGF-2 154 amino acids and the truncated FGF-2 147 amino acids recombinant proteins.
SIRT1 Peptide Reference: GTX85106-PEP SIRT1 peptide is used for blocking the activity of SIRT1 antibody (catalog number GTX8516). It usually blocks the antibody activity completely in Western blot by incubating the peptide with equal volume of antibody for 3 min at 37oC.
Recombinant Human FGF-2 (147) (Animal-Free) Reference: GFH28AF-10 Fibroblast Growth Factor 2 (FGF-2) is expressed by endothelial cells and is a mediator of angiogenesis. FGF-2 also has cardioprotective functions during heart injury. The application of FGF-2 is a critical component for embryonic stem cell culture systems and is necessary for maintaining cells in an undifferentiated state. Degredation of the full length FGF-2 N-terminus results in a truncated FGF-2 147 amino acids protein, when the protein is isolated from biological sources. The N-terminus extensions influence the localization of FGF-2 within the cell, but do not affect the biological activity of FGF-2. Therefore, there are no detectable differences in biological activity between the full length FGF-2 154 amino acids and the truncated FGF-2 147 amino acids recombinant proteins.
FAM82A1 Peptide Reference: GTX85107-PEP FAM82A1 peptide is used for blocking the activity of FAM82A1 antibody (catalog number GTX8517. It usually blocks the antibody activity completely in Western blot by incubating the peptide with equal volume of antibody for 3 min at 37oC.
Recombinant Human FGF-2 (147) (Animal-Free) Reference: GFH28AF-50 Fibroblast Growth Factor 2 (FGF-2) is expressed by endothelial cells and is a mediator of angiogenesis. FGF-2 also has cardioprotective functions during heart injury. The application of FGF-2 is a critical component for embryonic stem cell culture systems and is necessary for maintaining cells in an undifferentiated state. Degredation of the full length FGF-2 N-terminus results in a truncated FGF-2 147 amino acids protein, when the protein is isolated from biological sources. The N-terminus extensions influence the localization of FGF-2 within the cell, but do not affect the biological activity of FGF-2. Therefore, there are no detectable differences in biological activity between the full length FGF-2 154 amino acids and the truncated FGF-2 147 amino acids recombinant proteins.